全文获取类型
收费全文 | 31020篇 |
免费 | 2576篇 |
国内免费 | 700篇 |
专业分类
耳鼻咽喉 | 454篇 |
儿科学 | 1362篇 |
妇产科学 | 1397篇 |
基础医学 | 4175篇 |
口腔科学 | 202篇 |
临床医学 | 2699篇 |
内科学 | 4033篇 |
皮肤病学 | 263篇 |
神经病学 | 2407篇 |
特种医学 | 678篇 |
外国民族医学 | 18篇 |
外科学 | 3859篇 |
综合类 | 4507篇 |
现状与发展 | 4篇 |
预防医学 | 1522篇 |
眼科学 | 259篇 |
药学 | 2626篇 |
23篇 | |
中国医学 | 896篇 |
肿瘤学 | 2912篇 |
出版年
2024年 | 85篇 |
2023年 | 404篇 |
2022年 | 840篇 |
2021年 | 1165篇 |
2020年 | 1095篇 |
2019年 | 1002篇 |
2018年 | 932篇 |
2017年 | 1061篇 |
2016年 | 1134篇 |
2015年 | 1065篇 |
2014年 | 1695篇 |
2013年 | 1945篇 |
2012年 | 1421篇 |
2011年 | 1680篇 |
2010年 | 1378篇 |
2009年 | 1225篇 |
2008年 | 1331篇 |
2007年 | 1304篇 |
2006年 | 1311篇 |
2005年 | 1124篇 |
2004年 | 965篇 |
2003年 | 910篇 |
2002年 | 796篇 |
2001年 | 716篇 |
2000年 | 682篇 |
1999年 | 547篇 |
1998年 | 483篇 |
1997年 | 475篇 |
1996年 | 470篇 |
1995年 | 429篇 |
1994年 | 419篇 |
1993年 | 374篇 |
1992年 | 365篇 |
1991年 | 347篇 |
1990年 | 362篇 |
1989年 | 284篇 |
1988年 | 228篇 |
1987年 | 202篇 |
1986年 | 235篇 |
1985年 | 292篇 |
1984年 | 245篇 |
1983年 | 156篇 |
1982年 | 208篇 |
1981年 | 180篇 |
1980年 | 149篇 |
1979年 | 125篇 |
1978年 | 113篇 |
1977年 | 101篇 |
1976年 | 66篇 |
1975年 | 53篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
A. Tchelet T. Vogel D. Helman R. Guy C. Neospouolus V. Goffin J. Djiane A. Gertler 《Molecular and cellular endocrinology》1997,130(1-2):141-152
A new analogue of recombinant human growth hormone (hGH), hGH des(1–6,14) was expressed in Escherichia coli, refolded and purified to homogeneity. The mutation decreased the hormone's ability to bind lactogenic and somatogenic receptors through its site 1, and almost completely abolished its ability to bind these receptors through site 2, as evidenced by both binding and gel-filtration experiments. More specifically, the binding to prolactin receptors (PRLRs) from various species or their soluble recombinant extracellular domains (ECDs) was decreased 1.5–4-fold, whereas the binding to hGH receptor (hGHR) was decreased 10–85-fold. These changes caused an almost total loss of hormone agonistic activity in several in vitro bioassays and subsequently, the hGH des(1–6,14) analogue acquired antagonistic properties. This antagonistic activity was dependent upon modification of site 1. In those cases in which the binding was reduced only slightly, e.g. binding to rabbit PRLRs, hGH des(1–6,14) acted as a strong antagonist, whereas in others in which the binding of site 1 was reduced to a higher degree, such as other PRLRs and, in particular, hGHR, the antagonistic activity was correspondingly weaker. Circular dichroism spectra of the analogue suggested that these changes do not result from a decrease in overall -helix content, but rather from minor local structural modifications at the N-terminus. 相似文献
72.
S. W. J. LAMBERTS P. UITTERLINDEN T. VERLEUN 《European journal of clinical investigation》1987,17(4):354-359
Abstract. Several conflicting reports have been published with regard to the relationships between circulating growth hormone (GH), Somatomedin-C (SM-C) levels and clinical activity during different stages of therapy of acromegaly. We did not find a significant correlation between (fasting, post-prandial and mean 24-h) plasma GH and SM-C concentrations in twenty-two untreated acromegalic patients. There was a statistical significant correlation, however, if only the GH levels below 100 μg l-1 were considered (n=18 patients, P<0·01). The distribution of molecular forms of GH (‘little’, ‘big’ and ‘big-big’) did not differ between the four patients with GH levels above 100 μg l-1 and in four patients with levels between 40 μg l-1 and 80 μg l-1. Therefore, it is suggested that GH levels of 80–100 μg l-1 maximally activate Somatomedin-C production in man and that further increases in GH in general will not result in a further increase in SM-C generation. There was a significant correlation between GH and SM-C levels in forty-nine acromegalic patients after surgery and/or radiotherapy (P<0·001). In twenty-three of thirty-one patients with elevated SM-C levels the disease was subjectively still active, while this was the case in none of the patients with normal SM-C levels. In eight patients the disease was considered not to be clinically active any more, despite slightly increased SM-C levels. During long-term therapy of ten acromegalic patients for 16–108 weeks (mean 66±10) with 200–300 μg Sandostatin subcutaneously, clinical activity of the disease disappeared well before mean 24–h GH and SM-C levels reached the normal levels. There was a close correlation between mean 24-h GH and SM-C levels during Sandostatin therapy (P<0·001). ‘Clinical cure’ during this medical treatment was reached in five patients, as reflected by disappearance of subjective complaints, normalization of SM-C levels and 24-h mean GH levels of 2·8±0·2 μg l-1. Conclusions: (i) in untreated acromegaly, circulating GH and SM-C levels correlate well up to GH concentrations of 100 μg l-1. A further increase in GH does not result in a corresponding further increase in SM-C levels, suggesting a maximally activated production, without further GH-dependent capacity. (ii) Clinical ‘cure’ of acromegaly often occurs before normalization of the circulating SM-C levels. (iii) The measurement of plasma SM-C concentrations can be used well to adjust the dose and frequency of Sandostatin administration in acromegaly. This avoids the need of measuring extensive 24-h GH profiles. 相似文献
73.
本研究测定了荔枝果实发育期间内源激素含量的动态。结果表明果实发育前期细胞分裂素(CTK),生长素(IAA)含量较高;中期乙烯(Eth),赤霉素(GA),的含量较高,这与果实的生长发育及落果有密切相关。同时,果实发育前期应用外源CTK、中期应用GA、处理果穗可显著提高产果率。 相似文献
74.
Intermittent administration of low doses of human parathyroid hormone (h-PTH) has been reported to exhibit an anabolic effect
on bone, increasing its mass. We investigated the effects of intermittent administration of h-PTH on bone changes in streptozotocin-
(STZ-) induced diabetes mellitus (DM) rats by measuring bone mineral density and bone mineral contents and by bone histomorphometry.
Wistar rats, 7–8 months old, were used. Osteoporosis was induced by diabetes mellitus, which was established by an intraperitoneal
injection of STZ. Rats were separated into five groups: sham-injected, baseline control, vehicle-only-administered, and low-dose
(6.0μg/kg) or high-dose (60.0μg/kg) h-PTH-administered groups. h-PTH or vehicle was injected subcutaneously six times a week
for 4 weeks beginning 9 weeks after STZ administration. Bone mineral density and mineral contents were significantly lower
in the baseline control and vehicle groups than in the control group. The PTH-administered groups showed higher values compared
with both vehicle and baseline control groups. In bone histomorphometry, both bone volume and bone formation in the STZ group
were markedly reduced. The h-PTH-administered rats showed increase in both bone volume and bone formation, which are related
parameters, but administration of h-PTH did not alter the extent of eroded surface. Our results suggest that intermittent
administration of h-PTH is effective in activating bone formation and in preventing further bone loss in osteoporosis developed
by STZ-induced DM. 相似文献
75.
将Wistar大鼠分为三组:肝硬化组,给予四氯化碳等复合因素,给药组,除给CCl4等复合因素外,用赤栀黄合剂灌胃41天;正常组给以一般饮食及饮水。结果,与正常组及给药组相比,硬化组血T3、T4测定值低,甲状腺滤泡中胶质明显减少,滤泡细胞与胶质间空泡增多,滤泡上皮细胞内PAS阳性小滴数日增多。表明在实验性肝硬化期间甲状腺参与了抗疾病的代谢活动,其机理可能是肝硬化时肝细胞合成、转运T3,T4的蛋白质减少。运输中的T3,T4减少,活性甲状腺素不足,从而导致甲状腺代偿性功能活跃。赤栀黄合剂具有保肝,恢复甲状腺素水平的作用。 相似文献
76.
不同置换液量血液透析滤过治疗尿毒症皮肤瘙痒疗效观察 总被引:5,自引:0,他引:5
目的:观察不同置换液量血液透析滤过(HDF)对尿毒症皮肤瘙痒的治疗作用。方法:将30例并发皮肤瘙痒的维持性血液透析尿毒症患随机分为三个组,分别接受高置换液量后稀释HDF(置换液20L)、低置换液量后稀释HDF(置换液10L)和高通量血液透析治疗。均使用F60透析器,隔日1次,连续3次,其余治疗条件相同。对皮肤瘙痒症状定量计分,比较三组病人治疗前后皮肤瘙痒症状积分的改变以及血磷和甲状旁腺激素(PTH)的变化。结果:高置换液量HDF组治疗后皮肤瘙痒积分明显下降,有统计学意义。其余两组无差异。以皮肤瘙痒积分下降50%为有效计算,高置换液量HDF组7例有效,有效率70%;低置换液量HDF组3例有效。有效率30%;透析组1例有效,有效率10%。三组间比较有统计学差异。三组透析后血磷均明显下降,有统计学意义;PTH亦有下降,HDF组有统计学差异,HD组无统计学差异。结论:增加置换液量可以提高HDF治疗尿毒症皮肤瘙痒的疗效;HDF治疗尿毒症皮肤瘙痒疗效优于高通量血液透析;HDF清除PTH的效果高于HD。 相似文献
77.
During reproductive maturation of female insects, the acquisition of sexual receptivity is coordinated with ovarian development. Juvenile homone regulates vitellogenesis in the ovaries, but the action of this hormone in the development of sexual behavior is less well-understood. A strain ofDrosophila melanogaster carrying a mutation in theapterous gene(ap
4) was known to exhibit arrested vitellogenesis (rescuable by applying exogenous juvenile hormone), sterility of both sexes, and a deficiency of juvenile hormone. In this study, we examined the effects of mutations ofap on female receptivity and its relationship to juvenile hormone. We observed abnormally low female receptivity in homozygousap strains, and heteroallelic combinations ofap mutations exhibited low receptivity. For female receptivity,ap showed no dominance (i.e.,ap/ap
+ was intermediate betweenap/ap andap
+/ap
+). Low receptivity mapped genetically to theap locus. The reduction in female receptivity in these mutants is positively correlated with levels of juvenile hormone synthesized by their corpora allata.This work was supported in part by The Scheinfeld Center for Humans Genetics in the Social Sciences (J.R.), The National Science Foundation (BNS-882 1339 to J.R.), BARD (No. IS-1664-89R to D.S.), The Israel Cancer Research Fund (grant to D.S.), The Rekanati Foundation of Tel Aviv University (grant to D.S.), and The Israeli Fruit Council (award to M.A.) 相似文献
78.
Tatsuo Uchida Takahiko Tokumaru Hiroshi Kojima Katsura Nakagawaji Munehisa Imaizumi Toshio Abe 《Surgery today》1992,22(3):265-268
A 36 year old woman was admitted to our department because of a chest X-ray which showed multiple developing shadows. She underwent bilateral exploratory thoracotomies and a total 5 tumors were resected and pathologically diagnosed as benign metastasizing leiomyoma, the largest of which was positive for the progesterone receptor and negative for the estrogen receptor. A histogram of this tumor using a flow cytometer showed a diploid pattern and 4.6 percent of the S phase which was not more than that of a leiomyoma of the uterus from another patient. Two months later, she underwent a hysterectomy and bilateral salpingo-oophorectomy for treatment of the positive progesterone receptor in the pulmonary lesions. The resected uterine myoma and normal myometrium showed positive estrogen and progesterone receptors. For the subsequent 28 months she has been free of any further symptoms. Benign metastasizing leiomyoma of the uterus is a rare disease and very interesting because of its histological benignity and hormonal dependency. However, according to the literature, it is often confused in entity due to the fact that normal lung tissue also possesses hormone receptors. Considering our data on hormone receptors, it is rational to think that multiple leiomyomatous lesions in the lung should only be diagnosed as benign metastasizing leiomyomas when they possess positive estrogen and progesterone receptors. 相似文献
79.
We report a patient with metastatic thyroid carcinoma invading the esophagus in whom barium and MR examinations revealed an expansile intraluminal mass indistinguishable from that of a primary esophageal malignancy. Metastatic thyroid carcinoma should therefore be included in the differential diagnosis of an expansile esophageal mass. As in our patient, MR imaging may be useful for showing that the mass originates in the thyroid gland. 相似文献
80.